A
MRNA icon

Allianz’s Moderna MRNA Stock Holding History

Allianz’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Buy
4,326
+391
+10% +$20.2K ﹤0.01% 370
2026
Q1 		$200K Buy
3,935
+255
+7% +$11.9K ﹤0.01% 378
2025
Q4 		$109K Hold
3,680
– – ﹤0.01% 378
2025
Q3 		$95.1K Hold
3,680
– – ﹤0.01% 325
2025
Q2 		$102K Sell
3,680
-42
-1% -$1.11K ﹤0.01% 328
2025
Q1 		$106K Sell
3,722
-120
-3% -$4.26K ﹤0.01% 345
2024
Q4 		$151K Buy
3,842
+2,792
+266% +$133K ﹤0.01% 349
2024
Q3 		$70.2K Hold
1,050
– – ﹤0.01% 339
2024
Q2 		$125K Hold
1,050
– – ﹤0.01% 359
2024
Q1 		$112K Buy
+1,050
New +$106K ﹤0.01% 362

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Allianz's MRNA Position: Q2 2026 in Review

Allianz increased its Moderna (MRNA) stake by 9.9% in Q2 2026, buying an estimated $20.2K and bringing the position to 4,326 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #370.

Allianz first reported a position in MRNA in Q1 2024 and has held it in 10 quarters since. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Allianz held 4,326 shares of Moderna worth $303K as of Q2 2026.
  • Allianz bought 391 Moderna shares in Q2 2026, an estimated $20.2K.
  • Moderna made up ﹤0.01% of Allianz's portfolio in Q2 2026, its #370 holding.
  • Allianz first reported a position in Moderna in Q1 2024 and has held it in 10 quarters since.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.